Molecular Human Reproduction, Vol. 5, No. 5, 391-395,
May 1999
© 1999 European Society of Human Reproduction and Embryology
Functional evidence for divergent receptor activation mechanisms of luteotrophic and luteolytic events in the human corpus luteum
1 Department of Obstetrics and Gynecology, Umeå University Hospital, S-901 85 Umeå, and 2 Department of Physiology, Umeå University, S-901 87 Umeå, Sweden
Using a dispersed human luteal cell culture model, progesterone synthesis following treatment by incremental doses of human chorionic gonadotrophin (HCG) and the stable prostaglandin F2
(PGF2) analogue cloprostenol, alone or in combination, was related to corpora lutea (CL) mRNA transcript abundance coding for the luteinizing hormone (LH)/HCG receptor (LH-R) and PGF2-receptor (FP) by semi-quantitative reverse transcription–polymerase chain reaction (RT–PCR) in 33 otherwise healthy women, scheduled for surgery due to benign conditions. CL were grouped according to age, based on the occurrence of a preovulatory LH surge where post-LH days 2–5 were designated as early luteal phase; days 6–10 as mid-luteal phase and days 11–14 as late luteal phase. When exposed to HCG, maximal progesterone output was raised 2.2-fold (P = 0.08, n = 5) compared with untreated controls in the early CL, while it increased 5.7- and 4.6-fold in the mid- and late groups respectively (P < 0.05, n = 4 mid-luteal phase, n = 3 late luteal phase). This stimulation pattern was found to be concordant with the value of mRNA coding for LH-R in all groups (n = 6 early luteal phase, n = 5 mid-luteal phase, n = 6 late luteal phase). The integrated response to HCG and cloprostenol showed a dose-dependent 60% inhibition of progesterone production, but only in late luteal phase luteal cells (P < 0.01, n = 3). FP mRNA values were lowest in early luteal phase, and increased with the age of the CL. Interestingly, lowest CL tissue concentrations of the natural FP agonist PGF2, were found during mid-luteal phase while it increased again 1.6-fold during late luteal phase (P < 0.05, n = 8 versus mid-luteal phase, n = 6). Collectively, these data demonstrate that (i) the extrinsic functional control (or rescue of CL in the event of pregnancy) occurs when the sensitivity towards LH/HCG is maximal; and (ii) the demise of CL function is mediated via an acquisition of sensitivity towards the intrinsic luteolytic signal, PGF2, in the ageing CL.
corpus luteum/HCG/LH receptor/PGF2 receptor (FP)/progesterone
3 To whom correspondence should be addressed
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  H. Honkanen, S. Ranta, O. Ylikorkala, and O. Heikinheimo The kinetics of serum hCG and progesterone in response to oral and vaginal administration of misoprostol during medical termination of early pregnancy Hum. Reprod., September 1, 2002; 17(9): 2315 - 2319. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-L. Wu and M. C. Wiltbank Transcriptional Regulation of the Cyclooxygenase-2 Gene Changes from Protein Kinase (PK) A- to PKC-Dependence after Luteinization of Granulosa Cells Biol Reprod, May 1, 2002; 66(5): 1505 - 1514. [Abstract] [Full Text]
|
|
|
|
 |
|
 C. O. Stocco, L. F. Lau, and G. Gibori A Calcium/Calmodulin-dependent Activation of ERK1/2 Mediates JunD Phosphorylation and Induction of nur77 and 20alpha -hsd Genes by Prostaglandin F2alpha in Ovarian Cells J. Biol. Chem., January 25, 2002; 277(5): 3293 - 3302. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-J. Tsai, M.-H. Wu, P.-C. Chuang, and H.-M. Chen Distinct regulation of gene expression by prostaglandin F2{{alpha}} (PGF2{{alpha}}) is associated with PGF2{{alpha}} resistance or susceptibility in human granulosa-luteal cells Mol. Hum. Reprod., May 1, 2001; 7(5): 415 - 423. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Hosokawa, U. Ottander, P. Wahlberg, T. Ny, S. Cajander, and I.J. Olofsson Dominant expression and distribution of oestrogen receptor {beta} over oestrogen receptor {{alpha}} in the human corpus luteum Mol. Hum. Reprod., February 1, 2001; 7(2): 137 - 145. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Runesson, K. Ivarsson, P. Olof Janson, and M. Brännström Gonadotropin- and Cytokine-Regulated Expression of the Chemokine Interleukin 8 in the Human Preovulatory Follicle of the Menstrual Cycle J. Clin. Endocrinol. Metab., November 1, 2000; 85(11): 4387 - 4395. [Abstract] [Full Text]
|
|
|
|
|
|
F.M. Young, F.E. Rodger, P.J. Illingworth, and H.M. Fraser Cell proliferation and vascular morphology in the marmoset corpus luteum Hum. Reprod., March 1, 2000; 15(3): 557 - 566. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Ottander, K. Hosokawa, K. Liu, A. Bergh, T. Ny, and J. I. Olofsson A Putative Stimulatory Role of Progesterone Acting via Progesterone Receptors in the Steroidogenic Cells of the Human Corpus Luteum Biol Reprod, March 1, 2000; 62(3): 655 - 663. [Abstract] [Full Text]
|
|